{
  "resourceType": "CodeSystem",
  "id": "focus-characteristic-code",
  "meta": {
    "lastUpdated": "2023-03-26T15:21:02.749+11:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablecodesystem"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system <code>http://hl7.org/fhir/focus-characteristic-code</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">citation<a name=\"focus-characteristic-code-citation\"> </a></td><td>Citation</td><td>Used to reference a specific article.</td></tr><tr><td style=\"white-space:nowrap\">clinical-outcomes-observed<a name=\"focus-characteristic-code-clinical-outcomes-observed\"> </a></td><td>Observed outcomes are clinical outcomes</td><td>Used to denote a focus on clinical outcomes, ie evidence variable in role of outcome (measured variable) as observed is considered a &quot;clinical outcome&quot; (patient-important outcome such as mortality, symptoms, function or quality of life).</td></tr><tr><td style=\"white-space:nowrap\">population<a name=\"focus-characteristic-code-population\"> </a></td><td>Population</td><td>The population of interest.</td></tr><tr><td style=\"white-space:nowrap\">exposure<a name=\"focus-characteristic-code-exposure\"> </a></td><td>Exposure</td><td>The exposure of interest, such as an intervention.</td></tr><tr><td style=\"white-space:nowrap\">comparator<a name=\"focus-characteristic-code-comparator\"> </a></td><td>Comparator</td><td>The comparator (intervention or control state) of interest.</td></tr><tr><td style=\"white-space:nowrap\">outcome<a name=\"focus-characteristic-code-outcome\"> </a></td><td>Outcome</td><td>the outcome of interest.</td></tr><tr><td style=\"white-space:nowrap\">medication-exposures<a name=\"focus-characteristic-code-medication-exposures\"> </a></td><td>Medication exposures</td><td>Any medication exposures. A subset of exposures or interventions that are medications.</td></tr><tr><td style=\"white-space:nowrap\">study-type<a name=\"focus-characteristic-code-study-type\"> </a></td><td>Study type</td><td>Type of research study, such as randomized trial or case-control study.</td></tr></table></div>"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "cds"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 0
    }
  ],
  "url": "http://hl7.org/fhir/focus-characteristic-code",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.4.1960"
    }
  ],
  "version": "5.0.0",
  "name": "FocusCharacteristicCode",
  "title": "Focus Characteristic Code",
  "status": "active",
  "experimental": false,
  "date": "2020-12-28T16:55:11+11:00",
  "publisher": "HL7 (FHIR Project)",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://hl7.org/fhir"
        },
        {
          "system": "email",
          "value": "fhir@lists.hl7.org"
        }
      ]
    }
  ],
  "description": "Evidence focus characteristic code.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001",
          "display": "World"
        }
      ]
    }
  ],
  "caseSensitive": true,
  "valueSet": "http://hl7.org/fhir/ValueSet/focus-characteristic-code",
  "content": "complete",
  "concept": [
    {
      "code": "citation",
      "display": "Citation",
      "definition": "Used to reference a specific article."
    },
    {
      "code": "clinical-outcomes-observed",
      "display": "Observed outcomes are clinical outcomes",
      "definition": "Used to denote a focus on clinical outcomes, ie evidence variable in role of outcome (measured variable) as observed is considered a \"clinical outcome\" (patient-important outcome such as mortality, symptoms, function or quality of life)."
    },
    {
      "code": "population",
      "display": "Population",
      "definition": "The population of interest."
    },
    {
      "code": "exposure",
      "display": "Exposure",
      "definition": "The exposure of interest, such as an intervention."
    },
    {
      "code": "comparator",
      "display": "Comparator",
      "definition": "The comparator (intervention or control state) of interest."
    },
    {
      "code": "outcome",
      "display": "Outcome",
      "definition": "the outcome of interest."
    },
    {
      "code": "medication-exposures",
      "display": "Medication exposures",
      "definition": "Any medication exposures. A subset of exposures or interventions that are medications."
    },
    {
      "code": "study-type",
      "display": "Study type",
      "definition": "Type of research study, such as randomized trial or case-control study."
    }
  ]
}